Cochlear maintains full-year expectations despite half-year setback
The Australian hearing company still counts on reaching an underlying profit of AUD 290–305m (USD 200–210m) for the full year despite the HY23 profit receding 10%.
by marketwire, translated by daniel pedersen
Australian Cochlear has been rewarded by investors after the company maintained its expectations for the full year despite seeing a decline in sales in H1, a report revealed on Wednesday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Demant expecting to close divestment of Oticon Medical in Q2
For subscribers
Demant sets new powered-by-renewables goal
For subscribers
.jpg&w=384&q=75)
